The common PNPLA3 variant p.I148M, a major risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), exhibits increased ABHD5 binding affinity, thereby sequestering the co-factor from ATGL and impairing TAG degradation (56, 63). This evidence concerns the gene ABHD5 and metabolic dysfunction-associated steatotic liver disease.